A few of evaluation methods for drug release in vitro of sustained-controlled matrix tablets were introduced in this review.
本文简要介绍了几种缓控释骨架片药物体外释放行为的评价方法。
OBJECTIVE Breviscapine sustained-release tablets(BST)were formulated with hydroxypropyl-methylcellulose as the matrix material and the release mechanism of the tablets was studied.
目的以羟丙甲基纤维素为骨架材料制得灯盏花素缓释片，并对释药机制进行探讨。
Objective: to study the factors influencing the release mechanism of rutin from sustained release matrix tablets.
目的：考察芦丁缓释骨架片释药机制的影响因素。
Method: GBE sustained-release tablets were prepared by direct compression method using sodium carboxymethylcellulose CMC-Na and hydroxypropyl methylcellulose HPMC as matrix excipients.
方法：以溶胀性材料羧甲基纤维素钠和羟丙甲基纤维素为骨架材料，直接粉末压片制备银杏提取物缓释片。
Objective To study the influential factors of the release rate of neogambogic acid from sustained release matrix tablets.
目的研究新藤黄酸骨架片体外释药速率的影响因素。
The phase transition, barrier function and front movement of the gel layer are closely related to drug release process of hydrophlic gel matrix sustained-release tablets.
亲水凝胶骨架缓释片的释药过程与相转变过程、凝胶层屏障及区域前沿移动行为密切相关。
The phase transition, barrier function and front movement of the gel layer are closely related to drug release process of hydrophlic gel matrix sustained-release tablets.
亲水凝胶骨架缓释片的释药过程与相转变过程、凝胶层屏障及区域前沿移动行为密切相关。
应用推荐